Q32 Bio Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other
Q32 Bio Inc. (FIXX) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other of $1.39 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other $1.39M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other $733.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other $544.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other |
|---|---|
| 2025-12-31 | $1.39M 10-K · filed 2026-03-10 |
| 2024-12-31 | $733.00K 10-K · filed 2026-03-10 |
| 2023-12-31 | $544.00K 10-K · filed 2025-03-11 |